Effects of Sensory-Motor Integration Training in Patients with Idiopathic Parkinson's Disease
Trial
N/A
Completed
Dec. 26, 2024
Tandem DBS for Parkinson's Disease: A Pilot Study Utilizing STN/GPi + Hypothalamic Stimulation
Trial
N/A
Completed
Dec. 26, 2024
Neural Control of Breathing in Parkinson's Disease
Trial
N/A
Recruiting
Dec. 19, 2024
Pimavanserin for Sleep in Parkinson Disease
Trial
Early Phase 1
Withdrawn
Dec. 19, 2024
MST for Parkinson's Disease
Trial
N/A
Active, not recruiting
Dec. 19, 2024
Measurement and Modification of Threat Interpretation Bias in Neurodegenerative Movement Disorders (Aims 2 & 3)
Trial
N/A
Completed
Dec. 19, 2024
Constant Current Versus Constant Voltage Subthalamic Nucleus Deep Brain Stimulation in Patients with Parkinson's Disease
Trial
N/A
Recruiting
Dec. 18, 2024
Social Cognition and Personality Changes in Alzheimer's & Parkinson's Disease & Frontotemporal Lobar Degeneration
Trial
N/A
Completed
Dec. 17, 2024
An Open-label Study on the Clinical Efficacy of tDCS Intervention in PD
Trial
N/A
Completed
Dec. 17, 2024
A Novel Robotic System for Motor-cognitive Exercise for Patients With Parkinson's Disease
Trial
N/A
Recruiting
Dec. 16, 2024
fMRI-guided Transcranial Magnetic Stimulation Treatment for Parkinson's Disease
Trial
N/A
Completed
Dec. 15, 2024
Proteinopathies Expression in Skin of Neurodegenerative Disorders
Trial
N/A
Recruiting
Dec. 15, 2024
Evaluation of a Millimeter Wave Emission Bracelet for Improving Parkinson's Disease Symptoms
Trial
N/A
Completed
Dec. 12, 2024
Towards the Validation of a New Blood Biomarker for the Early Diagnosis of Parkinson's Disease
Trial
N/A
Recruiting
Dec. 10, 2024
VY-AADC02 for Parkinson's Disease With Motor Fluctuations (RESTORE-1)
Trial
Phase 1
Completed
Dec. 9, 2024
Facilitating Motor Skill Learning in Parkinson's Disease III
Trial
N/A
Completed
Dec. 9, 2024
A Letter from our CEO
News
Charco Neurotech
Dec. 6, 2024
Parkinson´s Disease, Aerobic Exercise and Photobiomodulation
Trial
N/A
Completed
Dec. 5, 2024
Nature-based Therapy Program for Parkinson's Disease (PARC)
Trial
N/A
Completed
Dec. 5, 2024
Combined Theta-gamma STN Stimulation for Verbal Fluency in Parkinson Disease
Trial
N/A
Completed
Dec. 5, 2024